High-dose twice daily thoracic radiotherapy in limited disease small-cell lung cancer

Enasidenib plus azacitidine vs azacitidine monotherapy in mutant-IDH2 ND-AML

Investigating KRd versus KTd in NDMM patients with high-risk cytogenetics

Patient reported outcomes for the CANDOR trial for multiple myeloma

COVID-19 and breast cancer: How should we treat our patients?

Comment: JAVELIN-100 for metastatic urothelial cancer

PARP inhibitors in prostate cancer: Choices of tests and how to test?

ASCO 2020: Breast cancer roundup

The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients with RAS-BRAF WT metastatic colorectal cancer

Comparing pevonedistat plus azacitidine versus azacitidine alone in patients with higher-risk MDS/CMML or low-blast AML

COVID-19: Optimising supportive care during active cancer treatment

KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H/dMMR colorectal cancer